Please Note:
This profile was automatically generated using 84 references found on the Internet. This information has been verified by Kevin Buckley. Learn more...
This profile was automatically generated using 84 references found on the Internet. This information has been verified by Kevin Buckley. Learn more...
Biography
I am a partner in the Life Sciences Practice of Spencer Fane, a general practice law firm having a focus on life sciences (biotech, biopharmaceutical, small molecule pharmaceutical, biologicals, medical instrument and device) commercialization. I have a decade of experience in patent preparation and prosecution, licensing, funding, regulatory and marketing issues. Before becoming an attorney, I...View all 84 references Web References
-
1. www.spencerfane.com
www.spencerfane.com/_FileLibra - [Cached]Published on: 7/15/2008 Last Visited: 7/15/2008
FN:Kevin Buckley -
2. www.spencerfane.com
www.spencerfane.com/Attorney/A - [Cached]Last Visited: 7/15/2008
Kevin BuckleySpencer Fane Britt & Browne
...
Kevin Buckley
Partner
...
Kevin Buckley is a partner in the Intellectual Property & Technology Practice in the St. Louis office.His practice focuses on biotechnology, life sciences, and pharmaceutical commercialization which includes patent preparation and prosecution, technology transfer and licensing, institutional collaborations, and intellectual property issues associated with venture finance.He also counsels his clients regarding pharmaceutical life-cycle management and regulatory matters pending before the FDA, USDA and EPA.Kevin's clients include Fortune 500 corporations, private research institutes, university systems, start-up companies, and entrepreneurs.
Previously, Mr. Buckley was the founder and President of Biotactica, LLC where he counseled c...
, Read More
Kevin Buckley is a partner in the Intellectual Property & Technology Practice in the St. Louis office.His practice focuses on biotechnology, life sciences, and pharmaceutical commercialization which includes patent preparation and prosecution, technology transfer and licensing, institutional collaborations, and intellectual property issues associated with venture finance.He also counsels his clients regarding pharmaceutical life-cycle management and regulatory matters pending before the FDA, USDA and EPA.Kevin's clients include Fortune 500 corporations, private research institutes, university systems, start-up companies, and entrepreneurs.
Previously, Mr. Buckley was the founder and President of Biotactica, LLC where he counseled clients in acquiring, protecting and commercializing biotechnologies and pharmaceutical technologies in the U.S. and abroad.Biotactica assisted clients obtain several million dollars in venture financing and developed commercialization strategies for life science entrepreneurs.Prior to that, he was with a large international law firm.
Before becoming an attorney, Kevin was a biochemist in both academics and industry where he investigated ribonucleic acid (RNA)-based therapeutics for treating viral infections and the role of purine nucleoside analogs in autoimmune diseases and cytokine mediated cell responses including apoptosis, rheumatoid arthritis, AIDS and cancers.
Kevin received a J.D. from the University of Pittsburgh where he was the Editor-in-Chief of The Pittsburgh Journal of Technology Law & Policy, and received a B.S. in Biochemistry from the University of California, San Diego where he was a Research Scholar.
In 2005, Kevin was named one of St. Louis Business Journal's "40 Under Forty," an annual award for becoming "a mover and shaker both in business and the St. Louis community."Since 2006, he has been listed in Who's Who in America and since 2007 in Who's Who in the World and Who's Who in American Law.Most recently, Kevin was selected as a member of "Who's Who in Technology" by the St. Louis Business Journal in July, 2007.
Kevin is a member of the Missouri Biotechnology Association, the International Society for Stem Cell Research, and the St. Louis Regional Chamber and Growth Association Plant and Life Science Network.He is a registered patent attorney with the U.S. Patent & Trademark Office and is admitted to practice law in Missouri.
, Read Less
Kevin Buckley is a partner in the Intellectual Property & Technology Practice in the St. Louis office.His practice focuses on biotechnology, life sciences, and pharmaceutical commercialization which includes patent preparation and prosecution, technology transfer and licensing, institutional collaborations, and intellectual property issues associated with venture finance.He also counsels his clients regarding pharmaceutical life-cycle management and regulatory matters pending before the FDA, USDA and EPA.Kevin's clients include Fortune 500 corporations, private research institutes, university systems, start-up companies, and entrepreneurs.
Previously, Mr. Buckley was the founder and President of Biotactica, LLC where he counseled clients in acquiring, protecting and commercializing biotechnologies and pharmaceutical technologies in the U.S. and abroad.Biotactica assisted clients obtain several million dollars in venture financing and developed commercialization strategies for life science entrepreneurs.Prior to that, he was with a large international law firm.
Before becoming an attorney, Kevin was a biochemist in both academics and industry where he investigated ribonucleic acid (RNA)-based therapeutics for treating viral infections and the role of purine nucleoside analogs in autoimmune diseases and cytokine mediated cell responses including apoptosis, rheumatoid arthritis, AIDS and cancers.
Kevin received a J.D. from the University of Pittsburgh where he was the Editor-in-Chief of The Pittsburgh Journal of Technology Law & Policy, and received a B.S. in Biochemistry from the University of California, San Diego where he was a Research Scholar.
In 2005, Kevin was named one of St. Louis Business Journal's "40 Under Forty," an annual award for becoming "a mover and shaker both in business and the St. Louis community."Since 2006, he has been listed in Who's Who in America and since 2007 in Who's Who in the World and Who's Who in American Law.Most recently, Kevin was selected as a member of "Who's Who in Technology" by the St. Louis Business Journal in July, 2007.
Kevin is a member of the Missouri Biotechnology Association, the International Society for Stem Cell Research, and the St. Louis Regional Chamber and Growth Association Plant and Life Science Network.He is a registered patent attorney with the U.S. Patent & Trademark Office and is admitted to practice law in Missouri.
Representative Technologies
Representative technologies with which Kevin has assisted clients include: biopharmaceuticals, small molecule pharmaceuticals, and biologics (e.g., therapeutic polynucleotides and polypeptides including siRNA, shRNA, miRNA, ribozymes, antisense DNA, antibodies, related fragments, vaccines, and enzymes); RNA interference (RNAi); medical imaging compounds and diagnostic methods; polynucleotide and polypeptide detection and screening; bioinformatics; structural proteomics; three-dimensional molecular modeling and drug design; stem cells and therapeutic cloning methods; transgenic plants and animals; microorganism/cell culture equipment and methods; biofuels and agriculture biotechnologies; and wet and dry nanotechnologies.Representative technologies with which Kevin has assisted clients include: biopharmaceuticals, small molecule pharmaceuticals, and biologics (e.g., therapeutic polynucleotides and polypeptides including siRNA, shRNA, miRNA, ribozymes, antisense DNA, antibodies, related fragments, vaccines, and enzymes); RNA interference (RNAi); medical imaging compounds and diagnostic methods; polynucleotide and polypeptide detection and screening; bioinformatics; structural proteomics; three-dimensional molecular modeling and drug design; stem cells and therapeutic cloning methods; transgenic plants and animals; microorganism/cell culture equipment and methods; biofuels and agriculture biotechnologies; and wet and dry nanotechnologies.
,Read Less
Representative technologies with which Kevin has assisted clients include: biopharmaceuticals, small molecule pharmaceuticals, and biologics (e.g., therapeutic polynucleotides and polypeptides including siRNA, shRNA, miRNA, ribozymes, antisense DNA, antibodies, related fragments, vaccines, and enzymes); RNA interference (RNAi); medical imaging compounds and diagnostic methods; polynucleotide and polypeptide detection and screening; bioinformatics; structural proteomics; three-dimensional molecular modeling and drug design; stem cells and therapeutic cloning methods; transgenic plants and animals; microorganism/cell culture equipment and methods; biofuels and agriculture biotechnologies; and wet and dry nanotechnologies. -
3. Biotactica
www.biotactica.com/ - [Cached]Published on: 6/2/2008 Last Visited: 6/2/2008
Kevin Buckleykbuckley@spencerfane.com
